Ju Mei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 7
- Co-authors
- Fangbao Ding (14 shared papers)Haibo Xiao (10 shared papers)Xiao Xie (9 shared papers)Fengqing Hu (8 shared papers)Jiang Lianyong (9 shared papers)Rui Bi (7 shared papers)Mingsong Wang (6 shared papers)Nan Ma (5 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Environmental Toxicology (2 papers)Aging (2 papers)The Annals of Thoracic Surgery (2 papers)Tumor Biology (2 papers)
- Partner nations
- China
In The Last Decade
Ju Mei
34 papers receiving 770 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 275
- Molecular Biology 466
- Pulmonary and Respiratory Medicine 142
- Oncology 104
- Genetics 32
Countries citing papers authored by Ju Mei
This map shows the geographic impact of Ju Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Mei more than expected).
Fields of papers citing papers by Ju Mei
This network shows the impact of papers produced by Ju Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Mei. The network helps show where Ju Mei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 66 | |
| 2 | 2015 | 65 | |
| 3 | 2016 | 46 | |
| 4 | 2011 | 46 | |
| 5 | 2009 | 39 | |
| 6 | 2015 | 38 | |
| 7 | 2015 | 36 | |
| 8 | Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells. | 2017 | 32 |
| 9 | 2015 | 31 | |
| 10 | 2018 | 30 | |
| 11 | 2014 | 29 | |
| 12 | 2023 | 29 | |
| 13 | 2019 | 28 | |
| 14 | 2014 | 26 | |
| 15 | 2020 | 26 | |
| 16 | 2016 | 24 | |
| 17 | 2015 | 24 | |
| 18 | 2021 | 22 | |
| 19 | 2015 | 20 | |
| 20 | 2011 | 18 |
About Ju Mei
Ju Mei is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 37 papers that have together received 774 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers), Circular RNAs in diseases (3 papers) and Coronary Artery Anomalies (3 papers). The work is most often cited by research in Cancer Research (275 citations), Molecular Biology (466 citations), Pulmonary and Respiratory Medicine (142 citations), Oncology (104 citations) and Genetics (32 citations). Ju Mei has collaborated with scholars based in China. Frequent co-authors include Fangbao Ding, Haibo Xiao, Xiao Xie, Fengqing Hu, Jiang Lianyong, Rui Bi, Mingsong Wang, Nan Ma, Zhiwei Xu and Yan Tan. Their work appears in journals such as Biochemical and Biophysical Research Communications, Environmental Toxicology, Aging, The Annals of Thoracic Surgery and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.